is glp-1 good The ABC's of GLP-1s: Benefits, Side Effects, and Success Stories — Nice Healthcare GLP-1 Agonists: Using Semaglutide, Tirzepatide,

Pinto says

Ethics declarations Competing interests R.D.G., I.K., P.J.C

CrossRef Assessing predictive value of contrast-enhanced ultrasound combined with doppler ultrasound for post-transcatheter arterial chemoembolization prognosis in hepatocellular carcinoma Jia-Jiao Qian, Min Xu, Yan-Song Ji World Journal of Gastrointestinal Surgery .2026;[Epub] CrossRef Adjuvant cytokine-induced killer cell immunotherapy in hepatocellular carcinoma: real-world data and 9-year extended follow-up of a randomized controlled trial Hyunjae Shin, Youngsu Park, Byeong Geun Song, Won-Mook Choi, Hyung Joon Han, Youngwoo Lee, Tae-Jin Song, Jong-Eun Yeon, Young-Suk Lim, Moon Haeng Hur, Yun Bin Lee, Eun Ju Cho, Su Jong Yu, Yoon Jun Kim, Joon Hyeok Lee, Jung-Hwan Yoon, Jeong-Hoon Lee Cancer Immunology, Immunotherapy .2026;[Epub] CrossRef First-line systemic therapy for hepatocellular carcinoma: new options Rashida V

One study found that dose-related local skin reactions were more common in patients treated with albiglutide compared to twice-daily exenatide or placebo

D 66 , 213221 (2010) Vagin, A

This led researchers to wonder if GIP agonists would even work in the population that needed them most